CCT244747 is a novel, potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs

PURPOSE: Many tumors exhibit defective cell cycle checkpoint control and increased replicative stress. CHK1 is critically involved in the DNA damage response and maintenance of replication fork stability. We have therefore discovered a novel, potent, highly selective, orally active, ATP competitive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Walton, Mike I, Eve, Paul D, Hayes, Angela, Valenti, Melanie R, De Haven Brandon, Alexis K, Box, Gary, Hallsworth, Albert, Smith, Elizabeth L, Boxall, Kathy J, Lainchbury, Michael, Matthews, Thomas P, Jamin, Yann, Robinson, Simon P, Aherne, G Wynne, Reader, John C, Chesler, Louis, Raynaud, Florence I, Eccles, Suzanne A, Collins, Ian, Garrett, Michelle D
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474704/
https://ncbi.nlm.nih.gov/pubmed/22929806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1322
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares